Commentary on "Paying for On-Patent Pharmaceuticals: Limit Prices and the Emerging Role of a Pay for Outcomes Approach".

Abstract

O VER THE PAST few decades, countries have experimented with a variety of approaches to controlling the cost of onpatent prescription drugs. From direct price controls, to health technology assessment, to market friendlier methods that encourage discounts, pharmaceutical policies reflect countries’ political, cultural, and economic environments. They are… (More)
DOI: 10.1097/JAC.0000000000000129

Cite this paper

@article{Seeley2016CommentaryO, title={Commentary on "Paying for On-Patent Pharmaceuticals: Limit Prices and the Emerging Role of a Pay for Outcomes Approach".}, author={Elizabeth Seeley}, journal={The Journal of ambulatory care management}, year={2016}, volume={39 2}, pages={150-1} }